267 related articles for article (PubMed ID: 31347950)
1. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
[TBL] [Abstract][Full Text] [Related]
2. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
3. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
4. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
5. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
Meskawi M; Becker A; Bianchi M; Trinh QD; Roghmann F; Tian Z; Graefen M; Perrotte P; Karakiewicz PI; Sun M
Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
[TBL] [Abstract][Full Text] [Related]
6. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
7. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
[TBL] [Abstract][Full Text] [Related]
8. Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.
Liao X; Qiu S; Wang W; Zheng X; Jin K; Zhang S; Bao Y; Yang L; Wei Q
Cancer Epidemiol; 2019 Apr; 59():221-226. PubMed ID: 30836219
[TBL] [Abstract][Full Text] [Related]
9. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
[TBL] [Abstract][Full Text] [Related]
12. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
13. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
14. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
15. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
16. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
Klatte T; Mauermann J; Heinz-Peer G; Waldert M; Weibl P; Klingler HC; Remzi M
J Endourol; 2011 Jun; 25(6):991-7. PubMed ID: 21568698
[TBL] [Abstract][Full Text] [Related]
17. Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis.
Yanagisawa T; Miki J; Shimizu K; Fukuokaya W; Urabe F; Mori K; Sasaki H; Kimura T; Miki K; Egawa S
Urol Oncol; 2020 Dec; 38(12):938.e1-938.e7. PubMed ID: 33036899
[TBL] [Abstract][Full Text] [Related]
18. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
[TBL] [Abstract][Full Text] [Related]
19. Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities.
Deuker M; Stolzenbach F; Rosiello G; Palumbo C; Martin T; Tian Z; Chun FK; Saad F; Shariat SF; Kapoor A; Karakiewicz PI
J Urol; 2020 Oct; 204(4):671-676. PubMed ID: 32250728
[TBL] [Abstract][Full Text] [Related]
20. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study.
Siech C; Incesu RB; Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Goyal JA; Tian Z; Saad F; Shariat SF; Tilki D; Longo N; Carmignani L; de Cobelli O; Ahyai S; Briganti A; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
Surg Oncol; 2024 Apr; 53():102047. PubMed ID: 38359547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
